Società | Nome | Borsa | Settore | Industria | 3 mesi | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Broadcom | Vienna | Tecnologia | Semiconduttori e apparecchiature per semiconduttori | 28,8% | 1,05 Bln € | 183,8x | -2,73 | 222,20 € | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Meta Platforms | Vienna | Tecnologia | Software e servizi IT | 26,4% | 1,76 Bln € | 29,5x | 0,48 | 692,50 € | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Discover Financial Services | Vienna | Finanziario | Servizi bancari | 20% | 45,81 Mrd € | 10,8x | 0,17 | 178,94 € | -2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Charles Schwab | Vienna | Finanziario | Servizi bancari e di Investimenti | 18,5% | 142,53 Mrd € | 27,1x | 1,57 | 78,72 € | -2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Visa | Vienna | Tecnologia | Software e servizi IT | 17,2% | 664 Mrd € | 33,7x | 2,43 | 339,40 € | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Goldman Sachs | Vienna | Finanziario | Servizi bancari e di Investimenti | 16% | 209,87 Mrd € | 15,7x | 0,21 | 617,60 € | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
AstraZeneca DRC | Vienna | Salute | Prodotti farmaceutici | 15,7% | 222,74 Mrd € | 33,1x | 1,75 | 72 € | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Expedia | Vienna | Consumi ciclici | Servizi ricettivi e di intrattenimento | 14% | 25,10 Mrd € | 21,7x | 0,31 | 193,68 € | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Morgan Stanley | Vienna | Finanziario | Servizi bancari e di Investimenti | 13,8% | 210,86 Mrd € | 17,1x | 0,33 | 131,24 € | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Mastercard | Vienna | Tecnologia | Software e servizi IT | 12,3% | 494,66 Mrd € | 40,7x | 2,29 | 542,30 € | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Eli Lilly | Vienna | Salute | Prodotti farmaceutici | 10,2% | 750,18 Mrd € | 74,8x | 0,73 | 837,20 € | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bristol Myers Squibb | Vienna | Salute | Prodotti farmaceutici | 9,2% | 108,93 Mrd € | -12,7x | 0,06 | 53,58 € | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Salesforce.com | Vienna | Tecnologia | Software e servizi IT | 8,7% | 301,54 Mrd € | 53,4x | 0,4 | 311,30 € | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Eiffage | Vienna | Industriali | Costruzione e ingegneria | 7,8% | 8,55 Mrd € | 8,4x | 1,08 | 90,20 € | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Gilead Sciences | Vienna | Salute | Prodotti farmaceutici | 5,8% | 126,23 Mrd € | 275,3x | -9,7 | 100,64 € | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ServiceNow | Vienna | Tecnologia | Software e servizi IT | 4,5% | 194,78 Mrd € | 142,8x | -7,77 | 941,20 € | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hess Corp | Vienna | Energia | Gas e petrolio | 4,2% | 42,70 Mrd € | 16,2x | 0,16 | 139,18 € | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Airbnb | Vienna | Tecnologia | Software e servizi IT | 4,2% | 84,51 Mrd € | 48,9x | -0,7 | 133,20 € | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Booking Holdings | Vienna | Consumi ciclici | Servizi ricettivi e di intrattenimento | 4% | 158,22 Mrd € | 33,8x | 11,02 | 4.795 € | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Adobe Systems | Vienna | Tecnologia | Software e servizi IT | -8,4% | 190,89 Mrd € | 36,9x | 7,42 | 440,75 € | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
NVIDIA | Vienna | Tecnologia | Semiconduttori e apparecchiature per semiconduttori | -9,3% | 3,16 Bln € | 52,9x | 0,22 | 129,74 € | 2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck & Co | Vienna | Salute | Prodotti farmaceutici | -9,9% | 203,90 Mrd € | 12,6x | 0 | 81,90 € | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Las Vegas Sands | Vienna | Consumi ciclici | Servizi ricettivi e di intrattenimento | -11,6% | 28,82 Mrd € | 21,4x | 0,96 | 40,32 € | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Intuit | Vienna | Tecnologia | Tecnologia finanziaria (fintech) e infrastrutture | -11,6% | 155,94 Mrd € | 56x | 4,44 | 562,80 € | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Novo Nordisk AS | Vienna | Salute | Prodotti farmaceutici | -16,1% | 338,65 Mrd € | 25,2x | 1,28 | 76,81 € | -2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |